Invention Grant
- Patent Title: Pseudopolymorphs of an HCV NS5A inhibitor and uses thereof
-
Application No.: US15032663Application Date: 2014-10-24
-
Publication No.: US10167298B2Publication Date: 2019-01-01
- Inventor: Michael McNevin , Yong Liu , Ian Mangion , Alfred Lee , Joyce Stellabott , Benjamin D. Sherry , Gary Martin , Kung-I Feng , Scott Schultz , Ryan Cohen , Yanfeng Zhang
- Applicant: MERCK SHARP & DOHME CORP.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Jeffrey P. Bergman; Catherine D. Fitch
- International Application: PCT/US2014/062085 WO 20141024
- International Announcement: WO2015/065817 WO 20150507
- Main IPC: A61K31/5365
- IPC: A61K31/5365 ; C07D498/04 ; A61P1/16 ; A61K45/06
Abstract:
The present invention relates to novel Pseudopolymorphs of Compound A, compositions comprising at least one Pseudopolymorph of Compound A, and methods of using the Pseudopolymorphs of Compound A for preparing compositions useful for treating or preventing HCV infection in a patient, wherein Compound A has the structure.
Public/Granted literature
- US20160311834A1 PSEUDOPOLYMORPHS OF AN HCV NS5A INHIBITOR AND USES THEREOF Public/Granted day:2016-10-27
Information query
